3Nuttall AG, Stehling CL, Christopher M,et al. Current transfusion practices of members of the American Society of Anesthesiologists. Anesthesiol, 2003, 99 (6) : 1433-1443.
3Vamvakas EC, Aubuchon JP, Can policy decisions in transfusion medicine be evidence-based? Transfusion Alternatives in Transfusion Medicine, 2003,5(2): 326
4卫生部．临床输血技术规范[S]．卫医发[2000]184号
5Heddle NM. The Pyramid of evidence-based transfusion medicine: definitions and concepts. Transfusion Alternative in Transfusion Medicine, 2003, 5(2) :297
6Hebert PC, Wells G, Blaychman MA, et al. A multi-center,randomized, controlled clinical trial of transfusion requirements in critical care. N Eng J Med, 1999, 340(6): 409
7Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med, 2001, 29(2):227
8Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA, 2002, 288(12)..1499
9王岳.涉及输血感染的若干法律问题[N].中国医学论坛报，2004—10—28(15)
10Williamson LM. Leukocyte depletion-what have we learnt?Transfusion Alternative in Transfusion Medicine, 2003, 5 (1) ,,26
1Hatzidakis AM, Mendlick RM, Mckillip T, et al. Preopera- tive autologous donation for total joint arthroplasty. An analy- sis of risk factors for allogenic transfusion[J]. J Bone Joint Surg Am, 2000, 82(1) :89-100.
2Salido JA, Marin LA, G6mez LA, et al. Preoperative hemo- globin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors[J]. J Bone Joint Surg Am, 2002, 84(2):216-220.
3Pierson JL, Hannon TJ, Earles DR. A blood-conservation al- gorithm to reduce blood transfusions after total hip and knee arthroplasty[J] J Bone Joint Surg Am, 2004, 86(7): 1512- 1518.
4Bell TH, Berta D, Ralley F, et al. Factors affecting perioper- ative blood loss and transfusion rates in primary total joint ar- throplasty:a prospective analysis of 1642 patients[J]. Can J Surg, 2009, 52(4) :295-301.
5American Society of Anesthesiologists Task Force on Perioper- ative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anes- thesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies[J]. Anesthesiology, 2006, 105 (1) : 198-208.
6Adunsky A, Lichtenstein A, Mizrahi E, et al. Blood transfu sion requirements in elderly hip fracture patients[J]. Arch Gerontol Geriatr, 2003, 36(1) :75-81.
7Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimising perioperative allogeneic blood transfusion[J]. Co- ehrane Database Syst Rev, 2010(4) : 1888.
8Zufferey PJ,Miquet M,Quenet S,et al.Tranexamic acid in hip fracture surgery:a randomized controlled trial[J].Br J Anaesth,2010,104:23-30.
9Carson JL,Terrin ML,Noveck H,et al.Liberal or restrictive transfusion in high-risk patients after hip surgery[J].N Engl J Med,2011,365:2453-2462.
